Eintrag weiter verarbeiten
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset.
Gespeichert in:
Zeitschriftentitel: | Journal of Clinical Oncology |
---|---|
Personen und Körperschaften: | , |
In: | Journal of Clinical Oncology, 29, 2011, 15_suppl, S. e13051-e13051 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
Schlagwörter: |
author_facet |
So, S. Zhao, B. So, S. Zhao, B. |
---|---|
author |
So, S. Zhao, B. |
spellingShingle |
So, S. Zhao, B. Journal of Clinical Oncology The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. Cancer Research Oncology |
author_sort |
so, s. |
spelling |
So, S. Zhao, B. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e13051 The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. Journal of Clinical Oncology |
doi_str_mv |
10.1200/jco.2011.29.15_suppl.e13051 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC5lMTMwNTE |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC5lMTMwNTE |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
American Society of Clinical Oncology (ASCO), 2011 |
imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2011 |
issn |
1527-7755 0732-183X |
issn_str_mv |
1527-7755 0732-183X |
language |
English |
mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
match_str |
so2011theeffectofnkcellimmunotherapyoncancerprognosisthroughitsboosterroleoncellularth1immunityanditscompensatorroletomaintainthecd4tcellsubset |
publishDateSort |
2011 |
publisher |
American Society of Clinical Oncology (ASCO) |
recordtype |
ai |
record_format |
ai |
series |
Journal of Clinical Oncology |
source_id |
49 |
title |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_unstemmed |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_full |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_fullStr |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_full_unstemmed |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_short |
The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_sort |
the effect of nk cell immunotherapy on cancer prognosis through its booster role on cellular (th1) immunity and its compensator role to maintain the cd4 t-cell subset. |
topic |
Cancer Research Oncology |
url |
http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e13051 |
publishDate |
2011 |
physical |
e13051-e13051 |
description |
|
container_issue |
15_suppl |
container_start_page |
0 |
container_title |
Journal of Clinical Oncology |
container_volume |
29 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792326406282149889 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:21:00.28Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+effect+of+NK+cell+immunotherapy+on+cancer+prognosis+through+its+booster+role+on+cellular+%28Th1%29+immunity+and+its+compensator+role+to+maintain+the+CD4+T-cell+subset.&rft.date=2011-05-20&genre=article&issn=1527-7755&volume=29&issue=15_suppl&pages=e13051-e13051&jtitle=Journal+of+Clinical+Oncology&atitle=The+effect+of+NK+cell+immunotherapy+on+cancer+prognosis+through+its+booster+role+on+cellular+%28Th1%29+immunity+and+its+compensator+role+to+maintain+the+CD4+T-cell+subset.&aulast=Zhao&aufirst=B.&rft_id=info%3Adoi%2F10.1200%2Fjco.2011.29.15_suppl.e13051&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792326406282149889 |
author | So, S., Zhao, B. |
author_facet | So, S., Zhao, B., So, S., Zhao, B. |
author_sort | so, s. |
container_issue | 15_suppl |
container_start_page | 0 |
container_title | Journal of Clinical Oncology |
container_volume | 29 |
description | |
doi_str_mv | 10.1200/jco.2011.29.15_suppl.e13051 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC5lMTMwNTE |
imprint | American Society of Clinical Oncology (ASCO), 2011 |
imprint_str_mv | American Society of Clinical Oncology (ASCO), 2011 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 1527-7755, 0732-183X |
issn_str_mv | 1527-7755, 0732-183X |
language | English |
last_indexed | 2024-03-01T12:21:00.28Z |
match_str | so2011theeffectofnkcellimmunotherapyoncancerprognosisthroughitsboosterroleoncellularth1immunityanditscompensatorroletomaintainthecd4tcellsubset |
mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
physical | e13051-e13051 |
publishDate | 2011 |
publishDateSort | 2011 |
publisher | American Society of Clinical Oncology (ASCO) |
record_format | ai |
recordtype | ai |
series | Journal of Clinical Oncology |
source_id | 49 |
spelling | So, S. Zhao, B. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e13051 The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. Journal of Clinical Oncology |
spellingShingle | So, S., Zhao, B., Journal of Clinical Oncology, The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset., Cancer Research, Oncology |
title | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_full | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_fullStr | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_full_unstemmed | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_short | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
title_sort | the effect of nk cell immunotherapy on cancer prognosis through its booster role on cellular (th1) immunity and its compensator role to maintain the cd4 t-cell subset. |
title_unstemmed | The effect of NK cell immunotherapy on cancer prognosis through its booster role on cellular (Th1) immunity and its compensator role to maintain the CD4 T-cell subset. |
topic | Cancer Research, Oncology |
url | http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e13051 |